Viewing Study NCT05705505


Ignite Creation Date: 2025-12-25 @ 3:30 AM
Ignite Modification Date: 2025-12-26 @ 2:11 AM
Study NCT ID: NCT05705505
Status: RECRUITING
Last Update Posted: 2023-12-12
First Post: 2023-01-19
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Study of Narazaciclib (ON 123300) Plus Letrozole in Endometrial Cancer and Other Gynecologic Malignancies
Sponsor: Traws Pharma, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module